BIOMAT Database Logo BIOMAT Database Logo

Prevention of toxicity of massive doses of A-methopterin by citrovorum factor. 1951

J H BURCHENAL, and G M BABCOCK

UI MeSH Term Description Entries
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D035843 Biomedical Research Research that involves the application of the natural sciences, especially biology and physiology, to medicine. Medical Research,Experimental Medicine,Investigational Medicine,Investigative Medicine,Research, Biomedical,Research, Medical,Medicine, Experimental,Medicine, Investigational,Medicine, Investigative

Related Publications

J H BURCHENAL, and G M BABCOCK
New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
July 1977, Cancer treatment reports,
J H BURCHENAL, and G M BABCOCK
Reversal of aminopterin and amethopterin toxicity by citrovorum factor.
December 1950, Journal of the American Medical Association,
J H BURCHENAL, and G M BABCOCK
Further observations on the effect of aminopterin, a-methopterin and citrovorum factor on the growth of transplantable avian lymphoid tumours.
December 1954, British journal of pharmacology and chemotherapy,
J H BURCHENAL, and G M BABCOCK
The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patients.
June 1988, Cancer,
J H BURCHENAL, and G M BABCOCK
Synthesis of citrovorum factor by Leuconostoc citrovorum; potentiation by ascorbic acid.
December 1953, Journal of bacteriology,
J H BURCHENAL, and G M BABCOCK
Thrombocytosis induced by citrovorum factor.
December 1969, Lancet (London, England),
J H BURCHENAL, and G M BABCOCK
[Citrovorum factor].
February 1952, Medicamenta,
J H BURCHENAL, and G M BABCOCK
CITROVORUM factor.
January 1951, Nutrition reviews,
J H BURCHENAL, and G M BABCOCK
Reversal of methotrexate toxicity in mice by a calcium salt of citrovorum factor and related compounds.
January 1981, Cancer treatment reports,
J H BURCHENAL, and G M BABCOCK
CITROVORUM factor conjugate.
September 1952, Nutrition reviews,
Copied contents to your clipboard!